Patent granted in India to the global alliance for TB Drug development, Inc and Janssen Pharmaceutica NV - GIP Research & Consultancy Services
Novel drugs against tuberculosis: a clinician's perspective | European Respiratory Society
Collaboration between TB Alliance and Tibotec offers hope of accelerated tuberculosis drug development | UNAIDS
Lancet study captures global interest with news of major milestone in hunt for new TB drugs
Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children
Partner Page-TB Alliance – Sovereign Sustainability & Development
PARTNERSHIPS
TB Alliance (@TBAlliance) / X
TB Alliance and Macleods partners for new therapy for highly drug-resistant TB - Express Pharma
MEMORANDUM OF UNDERSTANDING BETWEEN THE MEDICINES PATENT POOL FOUNDATION AND THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT This Me
The TB Alliance: overcoming challenges to chart the future course of TB drug development
TB Alliance: Improving Treatments Against TB
The Global Alliance for TB Drug Development - ppt video online download
TB Alliance Drug,TBA-354, enters Phase I Clinical Trials | Working Group for New TB Drugs
After 40 Years a New TB Drug is Approved | Taconic Biosciences
TB Alliance-Bayer Partnership Background Information. - ppt download
Impact on Industry: Critical Path to TB Drug Regimens | Critical Path Institute
In our fight against Tuberculosis, we have partnered with Global Alliance for TB Drug Development to offer affordable anti-TB medicines to… | Instagram
About TB Alliance
New drugs in development for treatment of TB | Download Table
From Drugs to Regimens: Transforming TB Drug Development | TB Alliance
Le Medicines Patent Pool et l'Alliance contre la tuberculose (TB Alliance) ont signé un protocole d'accord en vue de soutenir le développement plus poussé du sutezolid - MPP
Our Mission | TB Alliance
JCI - Confronting the scientific obstacles to global control of tuberculosis
Discovering and developing new treatments for tuberculosis – REVIVE
TB Alliance advances next-generation TB drug candidate into clinical testing
